Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acne Medication Market

Acne Medication Market Share

Report ID: GMI3010
Published Date: Nov 2022
Report Format: PDF

Download Free Sample

Acne Medication Market Share

Major enterprises operating in the acne medication sector are:

Allergan (AbbVie)
Galderma S.A
Reckitt Benckiser Group plc
Bausch Health
Stiefel Laboratories (GlaxoSmithKline plc)
Bayer AG
Almirall SA
Paratek Pharmaceuticals
Teva Pharmaceutical Industries
Akorn Operating LLC
Sun Pharmaceuticals
Pfizer Inc
Viatris
Mayne Pharmaceuticals
Procter & Gamble.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for acne medication crossed USD 9.9 billion in 2022 and is expected to observe over 5.5% CAGR from 2023 to 2032 owing to a rising prevalence of severe acne issues.

Oral segment is projected to depict over 6% CAGR from 2023 to 2032 due to the high efficacy of oral formulations in minimizing bacterial outgrowth and treating severe and inflammatory acne.

Pharmacies and drug store segment is expected to depict a growth of over 5.5% between 2023 and 2032 owing to the continuous efforts by leading industry participants to expand their pharmacy and drug store network in remote locations.

Europe acne medication market is poised to amass over USD 2.4 billion by 2032 driven by improving economic growth, rising disposable incomes, and increased consciousness about facial aesthetics.